Roger M. Perlmutter - Jun 8, 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
Director
Signature
/s/ Valerie Pierce, Attorney-in-fact
Stock symbol
NGM
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/10/2021, 05:34 PM
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Award $0 +46.2K $0.00 46.2K Jun 8, 2021 Common Stock 46.2K $17.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest one-third on the first anniversary of the date of grant, with the remaining shares vesting quarterly over the next two years, such that the option grant will be fully vested on the third anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.